Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity

Authors:	Chen Ping Doweyko Arthur M Norris Derek Gu Henry H Spergel Steven H Das Jagabundhu Moquin Robert V Lin James Wityak John Iwanowicz Edwin J McIntyre Kim W Shuster David J Behnia Kamelia Chong Saeho de Fex Henry Pang Suhong Pitt Sydney Shen Ding Ren Thrall Sara Stanley Paul Kocy Octavian R Witmer Mark R Kanner Steven B Schieven Gary L Barrish Joel C

Affiliation:	Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.

Abstract:

Keywords:
本文献已被 PubMed 等数据库收录！